A two-gene marker for the two-tiered innate immune response in COVID-19 patients
Fig 5
Expression level of S100A12 and IFI27 in COVID-19 patients and patients with other diseases (whole blood).
A) upper panel (dataset GSE161731), comparison of S100A12 and IFI27 expression in healthy controls and patients with COVID-19 (hospitalized and non-hospitalized) or other types of infection. B) lower panel (dataset GSE157103), comparison of S100A12 and IFI27 expression in intensive care unit (ICU) and non-ICU patients with or without COVID-19.